Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A C Leon

Showing results (1-10 of 122) with videos related to

Pageof 13
Sort By:
Clinical Therapeutics|May 17, 2001
Can placebo controls reduce the number of nonresponders in clinical trials? A power-analytic perspectiveA C Leon
Clinical Pharmacology and Therapeutics|January 21, 2012
Challenges in designing comparative-effectiveness trials for antidepressantsA C Leon
Archives of General Psychiatry|April 18, 2000
Placebo protects subjects from nonresponse: a paradox of powerA C Leon
The Journal of Clinical Psychiatry|March 7, 2001
Measuring onset of antidepressant action in clinical trials: an overview of definitions and methodologyA C Leon
The Psychiatric Clinics of North America|March 1, 1996
Recovery, chronicity, and levels of psychopathology in major depressionT I Mueller, A C Leon
General Hospital Psychiatry|March 1, 1997
Service utilization and expenditures for the treatment of panic disorderA C Leon, M Olfson, L Portera
Archives of General Psychiatry|October 1, 1995
More reliable outcome measures can reduce sample size requirementsA C Leon, P M Marzuk, L Portera
Psychopharmacology Bulletin|January 1, 1996
Lithium treatment of bipolar affective disorders under naturalistic followup conditionsJ F Goldberg, M Harrow, A C Leon
The American Journal of Psychiatry|December 1, 1994
Increase in fatal suicidal poisonings and suffocations in the year Final Exit was published: a national studyP M Marzuk, K Tardiff, A C Leon
The British Journal of Psychiatry. Supplement|April 1, 1995
The social costs of anxiety disordersA C Leon, L Portera, M M Weissman
Pageof 13

Showing results (1-10 of 122) with videos related to

Sort By:
Pageof 13
Clinical Therapeutics|May 17, 2001
Can placebo controls reduce the number of nonresponders in clinical trials? A power-analytic perspectiveA C Leon
Clinical Pharmacology and Therapeutics|January 21, 2012
Challenges in designing comparative-effectiveness trials for antidepressantsA C Leon
Archives of General Psychiatry|April 18, 2000
Placebo protects subjects from nonresponse: a paradox of powerA C Leon
The Journal of Clinical Psychiatry|March 7, 2001
Measuring onset of antidepressant action in clinical trials: an overview of definitions and methodologyA C Leon
The Psychiatric Clinics of North America|March 1, 1996
Recovery, chronicity, and levels of psychopathology in major depressionT I Mueller, A C Leon
General Hospital Psychiatry|March 1, 1997
Service utilization and expenditures for the treatment of panic disorderA C Leon, M Olfson, L Portera
Archives of General Psychiatry|October 1, 1995
More reliable outcome measures can reduce sample size requirementsA C Leon, P M Marzuk, L Portera
Psychopharmacology Bulletin|January 1, 1996
Lithium treatment of bipolar affective disorders under naturalistic followup conditionsJ F Goldberg, M Harrow, A C Leon
The American Journal of Psychiatry|December 1, 1994
Increase in fatal suicidal poisonings and suffocations in the year Final Exit was published: a national studyP M Marzuk, K Tardiff, A C Leon
The British Journal of Psychiatry. Supplement|April 1, 1995
The social costs of anxiety disordersA C Leon, L Portera, M M Weissman
Pageof 13